Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock transcription factor Y-linked 4, pseudogene (HSFY4P) is a nonfunctional genomic DNA sequence located on the Y chromosome that shares sequence similarity with functional heat shock factor genes, particularly HSFY family genes, which are involved in transcriptional activation of heat shock proteins. As a pseudogene, HSFY4P does not encode a functional protein product and is not an active transcriptional regulator. There are currently no reports of HSFY4P serving as a therapeutic or diagnostic target, and no evidence of a direct functional role in disease. In general, pseudogenes may exert regulatory effects such as acting as competing endogenous RNAs or sources of small interfering RNAs, but no such mechanism has been described for HSFY4P specifically[2][3][4][6]. Notes: - The gene is described as a **pseudogene**, meaning it is a nonfunctional version of a gene related to the heat shock transcription factor family. By definition, pseudogenes do not encode functional proteins and are therefore not considered therapeutic targets[2][6]. - Because "pseudogene" is part of the canonical name, and there is no evidence of functional protein product or targeting in pharmacology or drug discovery databases, **is_target** should be **false**, and **is_incorrect** should be **true** for "therapeutic target" context[2][3][6]. - There are no known drugs, mechanisms of action, biomarkers, or established safety concerns associated with HSFY4P. If you require information about a functional member of this gene family (e.g., HSFY, HSF1–HSFY), please specify, as the pseudogene itself is not a valid pharmacological or biomarker target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock transcription factor Y-linked 4, pseudogene (HSFY4P).